Andrea Rubbert-Roth Selected Research

Andrea Rubbert-Roth Research Topics

Disease

60	Rheumatoid Arthritis 02/2024 - 08/2003
14	Infections 04/2024 - 08/2003
7	Neoplasms (Cancer) 04/2024 - 07/2012
6	Necrosis 01/2023 - 01/2009
5	Rheumatic Diseases (Rheumatism) 01/2022 - 08/2003
4	Axial Spondyloarthritis 04/2024 - 12/2019
4	COVID-19 01/2023 - 01/2022
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 08/2003
3	Herpes Zoster 04/2024 - 01/2018
3	Psoriatic Arthritis 04/2024 - 04/2022
3	Inflammation (Inflammations) 02/2024 - 01/2017
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 09/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2015 - 05/2011
2	Ankylosing Spondylitis 04/2024 - 11/2023
2	Non-Radiographic Axial Spondyloarthritis 04/2024 - 11/2023
2	Synovitis 02/2024 - 08/2003
2	Arthralgia (Joint Pain) 02/2024 - 10/2023
2	Adult-Onset Still's Disease 01/2023 - 01/2020
2	Cytokine Release Syndrome 01/2023 - 06/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 12/2019
2	Giant Cell Arteritis (Horton Disease) 01/2023 - 06/2018
2	Castleman Disease (Castleman's Disease) 01/2023 - 06/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022 - 01/2018
2	Nasopharyngitis 04/2022 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 10/2015 - 05/2011
2	Vasculitis (Vasculitides) 11/2012 - 05/2011
1	Lymphopenia (Lymphocytopenia) 04/2024
1	Skin Neoplasms (Skin Cancer) 04/2024
1	Tenosynovitis 02/2024
1	Osteitis 02/2024
1	Diarrhea 10/2023
1	Neutropenia 10/2023
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 10/2023
1	Neuromyelitis Optica (Devic's Disease) 01/2023
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023
1	Opportunistic Infections (Opportunistic Infection) 04/2022
1	Oral Candidiasis (Thrush) 04/2022
1	Tuberculosis (Tuberculoses) 04/2022
1	Anemia 04/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Joint Diseases (Joint Disease) 12/2021
1	Stroke (Strokes) 10/2020

Drug/Important Bio-Agent (IBA)

18	tocilizumab (atlizumab)FDA Link 01/2023 - 03/2008
17	Rituximab (Mabthera)FDA Link 01/2023 - 02/2010
14	Antirheumatic Agents (DMARD)IBA 01/2023 - 01/2009
13	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 08/2003
9	Adalimumab (Humira)FDA Link 04/2024 - 01/2009
8	upadacitinibIBA 04/2024 - 01/2018
8	sarilumabIBA 10/2023 - 06/2017
7	Janus Kinase InhibitorsIBA 04/2024 - 06/2017
7	Abatacept (Orencia)FDA Link 02/2024 - 03/2014
6	Tumor Necrosis Factor InhibitorsIBA 12/2023 - 01/2009
6	Etanercept (Enbrel)FDA Link 01/2023 - 01/2009
5	Interleukin-6 (Interleukin 6)IBA 10/2023 - 03/2008
5	Infliximab (Remicade)FDA Link 01/2023 - 01/2009
5	Leflunomide (Arava)FDA LinkGeneric 01/2023 - 06/2017
4	baricitinibIBA 04/2023 - 06/2017
4	Messenger RNA (mRNA)IBA 01/2023 - 01/2022
4	Biosimilar PharmaceuticalsIBA 01/2023 - 03/2014
4	tofacitinibIBA 01/2023 - 06/2017
4	golimumab FDA Link 01/2023 - 03/2014
4	Certolizumab Pegol FDA Link 01/2023 - 03/2014
4	VaccinesIBA 10/2022 - 01/2022
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017 - 03/2008
3	GlucocorticoidsIBA 10/2023 - 06/2017
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023 - 06/2017
3	Immunoglobulin G (IgG)IBA 02/2022 - 02/2010
3	Monoclonal AntibodiesIBA 06/2018 - 06/2015
2	Aligeron (AS 2)IBA 04/2024 - 11/2023
2	Anti-Citrullinated Protein AntibodiesIBA 02/2024 - 10/2021
2	C-Reactive ProteinIBA 12/2023 - 10/2023
2	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2021
2	GLPG0634IBA 01/2023 - 01/2020
2	AutoantibodiesIBA 01/2023 - 02/2022
2	Chimeric Antigen ReceptorsIBA 01/2023 - 06/2018
2	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2010
2	mRNA VaccinesIBA 01/2022 - 07/2021
2	Janus KinasesIBA 01/2020 - 06/2017
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 05/2011
2	LipidsIBA 07/2012 - 12/2010
2	CytokinesIBA 12/2010 - 08/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 08/2003
1	acetyl 4-aminosalicylic acidIBA 02/2024
1	Prednisone (Sone)FDA LinkGeneric 10/2023
1	Immunomodulating AgentsIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 10/2022
1	vinyltriethoxysilane (VTES)IBA 04/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2022
1	HDL LipoproteinsIBA 02/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	AntibodiesIBA 10/2021
1	apremilastIBA 10/2021
1	Transaminases (Aminotransferases)IBA 10/2020

Therapy/Procedure

16	Therapeutics 10/2023 - 08/2003
2	Retreatment 12/2022 - 12/2011
1	Immunomodulation 01/2023